Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: Consequences on the efflux capacity of serum in the Fu5AH system

Atherosclerosis

Volumn 157, Issue 2, 2001, Pages 315-323

  Fournier, Natalie ^a,b   Atger, Véronique ^b   Cogny, Anne ^b   Vedie, Benót ^b   Giral, Philippe ^c   Simon, Alain ^d   Moatti, Nicole ^a,b   Paul, Jean Louis ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL BROUSSAIS   (France)

Author keywords

Cholesterol efflux; Fu5AH cells; High density lipoproteins; Hypertriglyceridemia; Phospholipid

Indexed keywords

HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ADULT; ARTICLE; CONTROLLED STUDY; EFFUSION; HEPATOMA CELL; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID COMPOSITION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SERUM;

ADULT; ANIMALS; BLOOD; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; CHOLESTEROL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, HDL; LIVER NEOPLASMS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PHOSPHOLIPIDS; RATS; REFERENCE VALUES; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 0034895542     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00730-9     Document Type: Article

References (59)

1. Lipids, risk factors and ischaemic heart disease
2. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
3. Triglycerides: A risk factor for coronary heart disease
4. Hypertriglyceridemia as a cardiovascular risk factor
5. Is hypertriglyceridemia an independent risk factor for coronary heart disease? The epidemiological evidence
6. Epidemiology of hypertriglyceridemia and cardiovascular disease
7. Triglyceride as a risk factor, epidemiology
8. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction
9. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism
10. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men
11. Atheroprotective mechanisms of HDL
12. Epidemiological aspects of high density lipoprotein cholesterol
13. Evidence that reverse cholesterol transport is stimulated by lipolysis of triglyceride-rich lipoproteins
14. Lipoprotein lipase: Structure, function and mechanism of action
15. New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis
16. Analysis of particle size and lipid composition as determinant of the metabolic clearance of human high density lipoproteins in a rabbit model
17. Triglyceride enrichment of HDL enhances the in vivo metabolic clearance of HDL apolipoprotein AI in healthy men
18. HDL metabolism in hypertriglyceridemic states: An overview
19. Plama phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis
20. Plasma phospholipid mass transfer rate: Relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters
21. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apo AI transgenic rats
22. HDL-phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum
23. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin: Cholesterol acyltransferase genes
24. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid
25. Scavenger receptor BI as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors
26. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo AI from HDL and subsequent formation of discoidal HDL
27. Hepatic lipase induces the formation of pre-β1 high density lipoproteins (HDL) from triacylglycerol rich HDL2
28. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre-β HDL
29. 2)
30. Estimation of the concentration of low-dnsity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
31. Cholesterol distribution between high density lipoprotein subfractions HDL2 and HDL3 determined in serum by discontinuous gradient gel electrophoresis
32. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux; relations between serum components and efflux, esterification and transfer
33. Rationale for treatment
34. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma
35. High density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease
36. Regulation of cholesteryl ester transfer protein (CETP) activity: Review of in vitro and in vivo studies
37. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterolester transfer protein and lecithin cholesteryl acyl transferase
38. VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein
39. Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma
40. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
41. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerosis cardiovascular disease in non-insulin dependent diabetes mellitus
42. Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjets
43. Fasting hypertriglyceridemia in non-insulin dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein metabolism
44. Heparin induced lipolysis in hypertriglyceridemic subjects results in the formation of atypical HDL particles
45. Clearance of post prandial and lipolytically modified human HDL in rabbits and rats
46. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice
47. Cholesteryl ester transfer protein's role in high density lipoprotein metabolism. Insights from studies with transgenic mice
48. Human plasma phospholipid transfer protein causes high density lipoprotein conversion
49. Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism
50. Plasma phospholipid transfer protein activity is related to insulin resistance: Impaired acute lowering by insulin in obese type II diabetic patients
51. Serum phospholipid transfer protein activity and genetic variation of the PLTP gene
52. Scavenger receptor BI promotes high density lipoprotein mediated cellular cholesterol efflux
53. High density lipoproteins and coronary heart disease
54. Coronary atherosclerosis wall thickening and vascular reactivity in humans. Elevated high density lipoprotein ameliorate abnormal vasoconstriction in early atherosclerosis
55. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
56. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins
57. HDL, its enzymes and its potential to influence lipid peroxidation
58. High density lipoprotein and lipoprotein oxidation
59. Quantification of human plasma phospholipid transfer protein (PLTP): Relationship between PLTP mass and phospholipid transfer actvity